NASDAQ:LSTA | Free Cash Flow | LISATA THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.08M$0.00-$3.08M
2025-12-31-$3.25M$0.00-$3.25M
2025-03-31-$5.4M$28,000.00-$5.43M
2024-12-31-$4.53M$0.00-$4.53M
2024-03-31-$7.03M$0.00-$7.03M
2023-12-31-$4.07M$0.00-$4.07M
2023-03-31-$8.2M
2022-12-31-$6.47M$26,000.00-$6.49M
2022-03-31-$5.64M
2021-12-31-$4.6M$0.00-$4.6M
2021-03-31-$7.98M$0.00-$7.98M
2020-12-31-$5.57M$6,000.00-$5.57M
2020-03-31-$4.24M$2,000.00-$4.24M
2019-12-31-$4.22M$0.00-$4.22M
2019-03-31-$5.49M$0.00-$5.49M
2018-12-31-$3.04M$0.00-$3.04M
2018-03-31-$6.3M$9,000.00-$6.31M
2017-12-31-$3.97M$16,522.00-$3.99M
2017-03-31-$10.09M$69,650.00-$10.16M
2016-12-31-$3.38M$31,330.00-$3.41M
2016-03-31-$8.03M$1.04M-$9.07M
2015-12-31-$8.73M$611,953.00-$9.34M
2015-03-31-$14.24M$344,530.00-$14.58M
2014-12-31-$10.9M$731,434.00-$11.64M
2014-03-31-$11.25M$1.24M-$12.49M
2013-12-31-$7.36M$1.74M-$9.11M
2013-03-31-$7.14M$53,571.00-$7.19M
2012-12-31-$9.62M$333,738.00-$9.96M
2012-03-31$2.11M$131,975.00$1.97M
2011-12-31-$3.41M$68,074.00-$3.47M
2011-03-31-$10.2M$707,224.00-$10.9M
2010-12-31-$5.3M$3.87M-$9.17M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$15.95M$28,000.00-$15.98M
2024-12-31-$19.36M$0.00-$19.36M
2023-12-31-$20.03M$0.00-$20.03M
2022-12-31-$21.17M$285,000.00-$21.46M
2021-12-31-$22.25M$60,000.00-$22.31M
2020-12-31-$8.82M$20,000.00-$8.84M
2019-12-31-$18.88M$0.00-$18.88M
2018-12-31-$19.99M$134,000.00-$20.12M
2017-12-31-$20.88M$135,000.00-$21.01M-91.44%
2016-12-31-$23.67M$1.1M-$24.77M
2015-12-31-$39.26M$3.19M-$42.44M
2014-12-31-$46.9M$3.66M-$50.55M
2013-12-31-$27.1M$2.69M-$29.79M
2012-12-31-$13.85M$531,315.00-$14.38M
2011-12-31-$20.93M$574,857.00-$21.5M
2010-12-31-$8.48M$16.38M-$24.85M